Spasticity is a condition that affects your muscles, making them tight or stiff. This can impact your ability to perform daily activities, such as walking, eating, and talking. The condition may also ...

Though many people experience muscle twitching, it's often incorrectly identified as a muscle spasm. While both are involuntary contractions of a muscle, muscle spasms and muscle twitching aren't ...

‌Hemifacial spasm is a disorder of the nerves and muscles that causes nonpainful involuntary twitching on one side of the face. Many people refer to hemifacial spasms as lip muscle spasms. Hemifacial ...

Electrical stimulation of the spinal cord is a promising strategy for reestablishing walking after spinal cord injury, recent studies show. But for patients suffering from muscle spasms, the ...

Tizanidine is a muscle relaxant. A doctor may prescribe tizanidine to manage spasticity resulting from various conditions, including multiple sclerosis, stroke, and spinal cord injuries. Although ...

Botulinum toxin therapy has emerged as a pivotal treatment in the management of spasticity, a debilitating neuromuscular condition characterised by increased muscle tone and hyperactive reflexes. By ...

Spastic cerebral palsy is a disorder that involves muscle stiffness. Symptoms and signs may include difficulty walking, trouble manipulating objects, and vision, hearing, or speech challenges.

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...

U.S. regulators have issued warnings to 18 websites that were selling fake or unapproved versions of Botox and similar wrinkle-relaxing injections. Researchers at the University of Ottawa have made a ...

Sen. Patrick Leahy, the president pro tempore of the Senate, said Wednesday that he went to the hospital Tuesday night because of “muscle spasms” he had been experiencing. Doctors, he told CNN, have ...

Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...